Premium Nahrungsergänzungsmittel | artgerecht

Thrombin Time – Definition, Normal Values & Significance

The thrombin time is a laboratory test used to evaluate blood coagulation. It measures how quickly thrombin converts fibrinogen into fibrin to form a clot.

Regular tips about health Regular tips about health

Things worth knowing about "Thrombin Time"

The thrombin time is a laboratory test used to evaluate blood coagulation. It measures how quickly thrombin converts fibrinogen into fibrin to form a clot.

What is the Thrombin Time?

The thrombin time (TT), also called the thrombin clotting time (TCT), is a coagulation test that assesses the final stage of the blood clotting cascade. It measures the time in seconds required for thrombin – a key clotting enzyme – to convert the soluble plasma protein fibrinogen into insoluble fibrin. Fibrin forms the structural framework of a stable blood clot and is essential for effective hemostasis (the process of stopping bleeding).

How is the Thrombin Time Measured?

A blood sample is drawn from the patient and plasma is separated by centrifugation. A standardized amount of thrombin is added to the plasma, and the time until a fibrin clot forms is recorded. The normal reference range is generally between 14 and 21 seconds, although this may vary slightly between laboratories. A prolonged thrombin time indicates a disturbance in this final step of the coagulation cascade.

Clinical Indications

The thrombin time is used in a variety of clinical situations, including:

Monitoring the effect of heparin therapy (heparin inhibits thrombin and prolongs the TT)
Investigating unexplained bleeding tendencies
Diagnosing or monitoring dysfibrinogenemia (qualitative fibrinogen defects) or afibrinogenemia (absence of fibrinogen)
Evaluating fibrinolysis (breakdown of blood clots) and detecting disseminated intravascular coagulation (DIC)
Monitoring patients receiving direct thrombin inhibitors such as dabigatran

Causes of a Prolonged Thrombin Time

A prolonged thrombin time may result from the following:

Fibrinogen deficiency (hypofibrinogenemia or afibrinogenemia): insufficient fibrinogen in the blood
Dysfibrinogenemia: structurally abnormal fibrinogen with impaired function
Heparin therapy: heparin directly inhibits thrombin, significantly prolonging the TT
Direct thrombin inhibitors (e.g., dabigatran, argatroban, hirudin)
Fibrinolysis: fibrin degradation products interfere with fibrin polymerization
Disseminated intravascular coagulation (DIC): consumption of fibrinogen and clotting factors
Liver dysfunction: reduced fibrinogen synthesis

Causes of a Shortened Thrombin Time

A shortened thrombin time is less common but can occur in states of markedly elevated fibrinogen levels, such as during acute inflammatory reactions, since fibrinogen is an acute-phase protein that rises in response to inflammation.

Comparison with Other Coagulation Tests

The thrombin time is one component of a comprehensive coagulation workup and is typically interpreted alongside other tests:

Prothrombin time (PT) / INR: evaluates the extrinsic coagulation pathway
Activated partial thromboplastin time (aPTT): evaluates the intrinsic coagulation pathway
Fibrinogen assay: quantitative measurement of fibrinogen levels (Clauss method)
Reptilase time: similar to the thrombin time but insensitive to heparin – used to differentiate between heparin effect and fibrinogen abnormalities

Clinical Relevance

The thrombin time is a simple, rapid, and informative test in coagulation diagnostics. It is particularly valuable in patients receiving anticoagulant therapy or in cases where a fibrinogen disorder is suspected. Results are always interpreted in the context of the clinical picture and other laboratory findings.

References

Kasper, D.L. et al.: Harrison's Principles of Internal Medicine. McGraw-Hill Education, New York.
Lippi, G. et al.: Thrombin time: an old but still important clotting test. PubMed / Laboratory Medicine, 2010.
World Health Organization (WHO): The Use of Anticoagulants in the Management of Thrombosis. WHO Technical Report, Geneva.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.